Filter
5285
Text search:
drug
access
Featured
Recommendations
472
New Publications
1401
Language
Document type
No document type
3144
Studies & Reports
888
Guidelines
633
Manuals
236
Strategic & Response Plan
177
Fact sheets
75
Training Material
68
Situation Updates
23
Infographics
16
Resource Platforms
12
Brochures
6
Online Courses
3
App
2
Videos
1
Countries / Regions
India
285
Global
188
Kenya
166
South Africa
140
Uganda
128
Ethiopia
120
Nigeria
115
Western and Central Europe
113
Tanzania
101
Nepal
90
Sierra Leone
87
Liberia
85
Malawi
85
Africa
85
Zambia
82
Myanmar / Burma
78
Latin America and the Carribbean
74
Bangladesh
69
Ghana
67
Rwanda
67
Eastern Europe
59
Namibia
56
Ukraine
55
Asia
44
Zimbabwe
43
Philippines
43
Cambodia
36
Lesotho
36
South–East Asia Region
36
Russia
27
Congo, Democratic Republic of
26
Botswana
26
Syria
24
Senegal
23
Indonesia
23
Mozambique
23
Burkina Faso
21
Eswatini/ Swaziland
19
East and Southern Africa
19
Cameroon
16
South Sudan
16
Brazil
16
Haiti
15
Colombia
15
West and Central Africa
15
Thailand
13
Eastern Europe and Central Asia
12
USA
11
Middle East and North Africa
11
Venezuela
11
Albania
11
Tajikistan
11
Guinea
10
Pakistan
10
China
10
Georgia
10
Vietnam
10
Afghanistan
9
Germany
9
Benin
9
Moldova
8
Sudan
7
Laos
7
North Macedonia
6
Mexico
6
Sri Lanka
6
Western Pacific Region
6
Armenia
6
North America
6
Mali
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Peru
5
Somalia
4
Turkey
4
Argentina
4
El Salvador
4
Libya
4
Yemen
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Madagascar
3
Bhutan
3
Palestine
3
Kyrgyzstan
3
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Ecuador
1
Greece
1
Paraguay
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Australia
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2023
Clinical Guidelines
429
Public Health
247
Women & Child Health
205
Key Resources
157
Capacity Building
84
Pharmacy & Technologies
55
Annual Report MEDBOX
1
Toolboxes
HIV
705
Mental Health
486
TB
484
AMR
257
NTDs
202
COVID-19
196
Pharmacy
151
NCDs
106
Malaria
101
Caregiver
100
Ebola & Marburg
78
Planetary Health
69
Refugee
67
Disability
62
Conflict
62
Rapid Response
60
Global Health Education
59
Health Financing Toolbox
51
2.0 Rapid Response
25
Cholera
22
Polio
19
Natural Hazards
18
Zika
16
Specific Hazards
14
Social Ethics
13
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall under three main categories: joint planning, key interventions, and overcoming barriers.
Biennial Report. SUBMITTED TO THE UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV AND AIDS
Reporting period: January 2012 – December 2013
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
The study sought to understand the factors that facilitate women to adhere to treatment and return to health facilities for routine care from their own perspective. The researchers focused on Malawi, Uganda and Zambia, early adopters of the global guidance to provide lifelong treatment for pregnant
...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.